Bicycle Therapeutics plc (BCYC) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Oil slips but stays near six-month highs on Saudi attacks
Tweet
Share
E-mailGet Alerts BCYC Hot Sheet
Join SI Premium – FREE
Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q1 EPS of ($0.88), $0.03 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $9.97 million versus the consensus estimate of $8.24 million.
For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens Community Bancorp, Inc. (CZWI) Tops Q3 EPS by 12c
- Medifast (MED) Tops Q3 EPS by 43c
- HSBC turns cautious short-term on stocks but remains bullish for 2027
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
